Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Presse Medicale (Paris, France : 1983)|May 30, 1992
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests]O Eloy, V Joly, J C Ghnassia, et al.
Journal of Clinical Microbiology|March 8, 2005
Use of microsatellite markers and gene dosage to quantify gene copy numbers in Candida albicansJ-M Costa, O Eloy, F Botterel, et al.
Current Pharmaceutical Design|August 8, 2018
Targeted Liposomes for siRNA Delivery to CancerJosimar O Eloy, Raquel Petrilli, Giovanni Loureiro Raspantini, et al.
Colloids and Surfaces. B, Biointerfaces|August 25, 2017
Immunoliposomes: A review on functionalization strategies and targets for drug deliveryJosimar O Eloy, Raquel Petrilli, Lucas Noboru Fatori Trevizan, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 27, 2016
Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma CellsRaquel Petrilli, Josimar O Eloy, Renata F V Lopez, et al.
Current Pharmaceutical Design|September 2, 2015
Stimuli-Responsive Nanoparticles for siRNA DeliveryJosimar O Eloy, Raquel Petrilli, Renata F V Lopez, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2017
Preparation of Immunoliposomes by Direct Coupling of Antibodies Based on a Thioether BondRaquel Petrilli, Josimar O Eloy, Robert J Lee, et al.
Annales De Biologie Clinique|July 1, 1997
[Phenotype and genotype analysis of Torulopsis glabrata isolated from nosocomial infections]O Eloy, A Lallali, P Pina, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 27, 2016
Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer CellsJosimar O Eloy, Raquel Petrilli, Robert W Brueggemeier, et al.
Pageof 6